CRT 2026

Panel Discussion | Diagnosis and Management of Pulmonary Embolism

Moderator(s)

• 

  Ramzi F. Khalil, MD

  Cardiac Catherization Lab Director
  Allegheny General Hospital , Pennsylvania, United States

  Disclosure(s): Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Kenneth Rosenfield, MD, MHCDS

  section head, vascular medicine and intervention
  Massachusetts General Hospital
  boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  Rachel Rosovsky, MD, MPH

  Associate Professor, Harvard Medical school
  Massachusetts General Hospital
  Boston, Massachusetts, United States

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Vikas Aggarwal, MD, MPH

  Director of venous and pulmonary vascular interventions
  Henry Ford Health System
  Ann Arbor, Michigan, United States

  Disclosure(s): No financial relationships to disclose
• 

  Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI

  Professor of Medicine
  New York University School of Medicine
  New York University School of Medicine
  New York, New York, United States

  Disclosure(s): Abbott Vascular, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Jupiter Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Stryker: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Riyaz Bashir, MD

  Director Vascular and Endovascular Medicine
  Mayo Clinic Florida
  Jacksonville, Florida, United States

  Disclosure(s): Thrombolex: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-privately held company (Ongoing)
• 

  Sadia Ilyas, MD

  Vascular Surgeon
  MedStar Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure information not submitted.
• 

  Robert Lookstein, MD

  Professor of Radiology & Surgery Vice Chair, Interventional Services
  Mount Sinai Health System
  New York, New York, United States

  Disclosure information not submitted.
• 

  Gregory Piazza, MD

  Staff Physician
  Brigham and Women's Hospital
  Boston, Massachusetts, United States

  Disclosure(s): BMS/Pfizer, Janssen, Alexion, Bayer, Amgen, BSC, Esperion, Regeneron, NIH 1R01HL164717-01: Grant/Research Support (Ongoing); BSC, Amgen, Thrombolex, Penumbra, BMS/Pfizer, NAMSA, BMS, Janssen: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Ido Weinberg, MD

  Physician
  Massachusetts General Hospital
  Boston, Massachusetts, United States

  Disclosure(s): Nova Pulse: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)